ADMA Biologics, Inc. (ADMA) a biopharmaceutical company focused on commercializing specialty plasma-derived biologics, confirmed that the U.S. Food and Drug Administration (FDA) has approved the
It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention. The
Usio Inc. (USIO) stock soared 41.54% to $2.59 in the pre-market trading after declaring that it has entered into a non-binding Letter of Intent (LOI)
ADMA Biologics Inc [NASDAQ: ADMA] is a top performer this afternoon. Like other companies that deal in plasma biologics, this stock has benefitted from the
The markets are up this morning driven by news that the U.S had approved a COVID-19 treatment. Yesterday, the U. S FDA issued an emergency
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.